Brainsway Ltd. revenue
Brainsway Ltd.'s revenue was $52.2m in fiscal 2025, up 27.3% on the year before. Since fiscal 2017 ($11.1m) it has grown at a compound 21.3% a year.
Revenue history
| Fiscal year | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11 | 16 | 23 | 22 | 30 | 27 | 32 | 41 | 52 |
| Growth on the year before | — | +47.1% | +40.9% | −4.5% | +34.5% | −8.4% | +17.0% | +29.0% | +27.3% |
| Gross profit | 9 | 13 | 18 | 17 | 23 | 20 | 23 | 31 | 39 |
| Gross margin | 76.7% | 78.1% | 77.8% | 77.1% | 77.7% | 73.8% | 73.9% | 74.6% | 75.4% |
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Brainsway Ltd. | $52.2m | 27.3% | — |
| Iridex Corp | $51.6m | 3.7% | -2.9% |
| Senseonics Holdings, Inc. | $48.5m | 90.6% | 38.0% |
| Apyx Medical Corp | $58.4m | 25.6% | 7.2% |
| Clearpoint Neuro, Inc. | $45.5m | 32.5% | 26.8% |
| Lensar, Inc. | $60.3m | 3.3% | 16.4% |
Compare with peers
- Iridex Corp revenue
- Senseonics Holdings, Inc. revenue
- Apyx Medical Corp revenue
- Clearpoint Neuro, Inc. revenue
- Lensar, Inc. revenue
Head to head: BWAY vs IRIXBWAY vs SENSAPYX vs BWAY
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies